Listen to Gynecologic Oncology
Listen to the latest news from the experts in your field.
- Update frequency
- every 33 days
- Average duration
- 22 minutes
- Episodes
- 54
- Years Active
- 2019 - 2025
Understanding the Implications of the Platinum-Free Interval in Endometrial Cancer
Prophylactic chemotherapy to prevent post-molar gestational trophoblastic disease - a long journey and a remarkable study
Clinical trials: Panacea or pitfall
Editor’s Choice: Clinical trial enrollment during first course of gynecologic cancer treatment and survival
Editorial: Clinical trials are not the solution to inequities in cancer care
Implementation and impact of a financial navigation program in gynecologic oncology
Editor’s Choice: Implementation of a financial navigation program in gynecologic oncology
Editorial: Financial toxicity: moving from describing the problem toward developing interventions
Hosted by:
D…
Primary Surgery versus Radiotherapy for Inguinal Lymph Nodes in Vulvar Cancer
Shifting trends and sicker patients - the future of gynecologic cancer
Editor’s choice: Shifting trends and sicker patients: Reassessing hysterectomy performed for benign indications by gynecologic oncologists
Editorial: Who you gonna call?
Hosted by:
David E. Cohn, MD, …
2023 FIGO staging for endometrial cancer: a reappraisal on the path to continuous improvement
Reviews: 2023 changes to FIGO endometrial cancer staging: Counterpoint; 2023 FIGO staging system for endometrial cancer: The evolution of the revolution
Editorial: 2023 FIGO staging for endometrial c…
Editor's Choice: SENTIREC-endo study: Is the juice worth the squeeze?
Editor’s Choice Paper:
Identifying safe diagnostic algorithms for sentinel lymph node mapping in high-risk endometrial cancer: The SENTIREC-endo study
Editorial:
Sentinel lymph node biopsy in high-risk…
Editor's Choice: Caring for the Caregiver
Editor’s Choice Paper:
Experiences of patients with peritoneal carcinomatosis-related complex care needs and their caregivers
Editorial:
The importance of family-focused care in the setting of advance…
Editor’s Choice: Lunchbox Trial
Editor’s Choice Paper:
Lunchbox trial: A randomized phase III trial of cisplatin and irradiation followed by carboplatin and paclitaxel versus sandwich therapy of carboplatin and paclitaxel followed …
Editor’s Choice: Optimization of endometrial cancer survivorship through modification of lifestyle factors
Editor’s Choice Paper:
Associations between modifiable lifestyle factors and health-related quality of life among endometrial carcinoma survivors - A cross-sectional study
Hosted by:
Gregg Nelson, MD,…
October 2023 Editor’s Choice: OS updates for Imagyn50
Editor’s Choice Paper:
Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed s…
September 2023 Editor’s Choice: Is now the time to begin thromboprophylaxis for all patients with advanced ovarian cancer, including those undergoing neoadjuvant chemotherapy?
Editor’s Choice Paper:
Incidence of venous thromboembolism in patients with advanced stage ovarian cancer undergoing neoadjuvant chemotherapy: Is it time for thromboprophylaxis?
Editorial: Universal …
August 2023 Editor’s Choice: What is your center doing to improve genetic testing following abnormal MMR results in endometrial cancer?
Editor’s Choice Papers:
Improving genetic testing following abnormal mismatch repair immunohistochemistry results in endometrial cancer
Editorial: Universal testing – Should it be that hard? Probably…